PMID- 10217323 OWN - NLM STAT- MEDLINE DCOM- 19990622 LR - 20220331 IS - 0022-3573 (Print) IS - 0022-3573 (Linking) VI - 51 IP - 2 DP - 1999 Feb TI - Lavender oil inhibits immediate-type allergic reaction in mice and rats. PG - 221-6 AB - We studied the effects of lavender oil on mast cell-mediated immediate-type allergic reactions in mice and rats. Lavender oil (1:500, 1:100, 1:10, 1:1, 1:0) inhibited concentration-dependently mast cell-dependent ear swelling response induced by compound 48/80 in mice by both topical and intradermal application. Lavender oil (1:500, 1:100, 1:10, 1:1, 1:0) inhibited concentration-dependently passive cutaneous anaphylaxis induced by anti-dinitrophenyl (DNP) IgE in rats by both topical and intradermal application. Lavender oil (1:500, 1:100, 1:10, 1:1, 1:0) also inhibited concentration-dependently the histamine release from the peritoneal mast cells by compound 48/80 or anti-DNP IgE. Moreover, lavender oil (1:1000, 1:100, 1:10, 1:0) had a significant inhibitory effect on anti-DNP IgE-induced tumour necrosis factor-alpha secretion from peritoneal mast cells. These results indicate that lavender oil inhibits immediate-type allergic reactions by inhibition of mast cell degranulation in-vivo and in-vitro. FAU - Kim, H M AU - Kim HM AD - Department of Oriental Pharmacy, College of Pharmacy, Wonkwang University, Iksan, Chonbuk, South Korea. FAU - Cho, S H AU - Cho SH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Pharm Pharmacol JT - The Journal of pharmacy and pharmacology JID - 0376363 RN - 0 (Dinitrobenzenes) RN - 0 (Oils, Volatile) RN - 0 (Plant Extracts) RN - 0 (Plant Oils) RN - 0 (Tumor Necrosis Factor-alpha) RN - 37341-29-0 (Immunoglobulin E) RN - 4091-50-3 (p-Methoxy-N-methylphenethylamine) RN - ZBP1YXW0H8 (lavender oil) SB - IM MH - Anaphylaxis/etiology/prevention & control MH - Animals MH - Dinitrobenzenes/immunology MH - Dose-Response Relationship, Drug MH - Female MH - Histamine Release/drug effects MH - Hypersensitivity, Immediate/chemically induced/*prevention & control MH - Immunoglobulin E/adverse effects MH - Lavandula MH - Male MH - Mast Cells/drug effects/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Mice, Inbred Strains MH - Oils, Volatile/pharmacology/*therapeutic use MH - Peritoneum/cytology MH - Plant Extracts/pharmacology/*therapeutic use MH - *Plant Oils MH - Plants, Medicinal/chemistry MH - Rats MH - Rats, Wistar MH - Skin Diseases/etiology/prevention & control MH - Tumor Necrosis Factor-alpha/drug effects/metabolism MH - p-Methoxy-N-methylphenethylamine/adverse effects EDAT- 1999/04/27 00:00 MHDA- 1999/04/27 00:01 CRDT- 1999/04/27 00:00 PHST- 1999/04/27 00:00 [pubmed] PHST- 1999/04/27 00:01 [medline] PHST- 1999/04/27 00:00 [entrez] AID - 10.1211/0022357991772178 [doi] PST - ppublish SO - J Pharm Pharmacol. 1999 Feb;51(2):221-6. doi: 10.1211/0022357991772178.